GlassScriptPhysician profile
Stephanie E Bank
NPI 1255358933
$3,224.98
in general payments reported to CMS, 2019-2025
17 companies · $1,216 in 2025
The $1,216 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $36.18 · 2021: $132 · 2022: $188 · 2023: $607 · 2024: $900 · 2025: $1,216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,722.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $611.22 | 2024-2025 | Miebo, Xiidra, Scoutpro Osmolarity System |
| Coopervision INC. | $320.44 | 2024-2025 | Misight Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $295.02 | 2021-2025 | Acuvue |
| Alcon Vision LLC | $285.67 | 2019-2023 | Hydrus Microstent |
| Johnson & Johnson Surgical Vision, INC. | $265.93 | 2024-2025 | Tecnis Iol |
| Sight Sciences, INC. | $233.57 | 2023-2025 | Omni Surgical System |
| Lumenis Be INC | $211.53 | 2023 | M22 |
| Sun Pharmaceutical Industries INC. | $146.60 | 2019-2024 | |
| Amgen INC. | $121.85 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $121.85 | 2025 | Xdemvy |
| Ani Pharmaceuticals, INC. | $109.21 | 2025 | Purified Cortrophin Gel |
| Rxsight INC | $107.08 | 2022 | |
| Glaukos Corporation | $106.97 | 2025 | Kxl System (Not Refurbished) |
| Harrow Eye, LLC | $105.32 | 2025 | Vevye |
| Horizon Therapeutics Plc | $99.42 | 2023 | Tepezza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Samsara Vision | $63.90 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Bank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.